Brain glucosamine boosts protective glucoprivic feeding - Wikidata - awgldk - TriplyDB

Brain glucosamine boosts protective glucoprivic feeding

Brain glucosamine boosts protective glucoprivic feeding

http://www.wikidata.org/entity/Q33772319

about

Insights into the role of neuronal glucokinase Brain glucose sensing, glucokinase and neural control of metabolism and islet function BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding.Glucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons.Recurrent hypoglycemia is associated with loss of activation in rat brain cingulate cortex.Stimulation of feeding by three different glucose-sensing mechanisms requires hindbrain catecholamine neurons.Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.

P2860

Q26748833-EC1E394F-869F-4CCE-9D14-FB4B5F695D2B Q26991502-D65D858C-BADF-49E9-96F9-ABD8FA6DC957 Q34097575-B074B817-35DE-4556-97E9-EF77697F324F Q35097342-0A2C9329-98FF-4195-AACC-3542970321E7 Q35893491-E9F9D5EB-3BD8-4D0E-80D0-E4F75CEB8792 Q37578146-72D63802-2B2F-4D32-BB3A-73D65AFA57FF Q41848845-8D4D1391-D8E5-4476-8577-47113971C386

P2860

Brain glucosamine boosts protective glucoprivic feeding

http://www.wikidata.org/entity/Q33772319

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Brain glucosamine boosts protective glucoprivic feeding

@ast

Brain glucosamine boosts protective glucoprivic feeding

@en

type

label

Brain glucosamine boosts protective glucoprivic feeding

@ast

Brain glucosamine boosts protective glucoprivic feeding

@en

prefLabel

Brain glucosamine boosts protective glucoprivic feeding

@ast

Brain glucosamine boosts protective glucoprivic feeding

@en

P1433

Q33772319-4B1BB08B-1803-49F5-BF87-C8EE35D32FF3

P1476

Q33772319-F9B57755-DD0C-4424-9EAF-E7E711CC01D4

P2093

Q33772319-02D611F4-710D-4D18-B268-3466D8FF830A

Q33772319-069CD42C-B402-4A37-A6EB-914009110893

Q33772319-227D57B8-BDC3-4A64-842F-ED6E876321A2

Q33772319-D1F4DD2D-58BF-4EC5-BA68-E5F570CFD60A

Q33772319-E385C39D-CE46-4126-9F17-F76F9E540790

Q33772319-F7DFB05F-BFCD-4B5D-AFDC-F2B22584A9BF

P2860

Q33772319-02BAF176-3872-4B80-974F-9F3FE0B99340

Q33772319-08875DCD-857F-41D8-BE0E-12B66E306C44

Q33772319-089F91C6-C055-41BD-8C4E-3F2870BBA37C

Q33772319-14EF1CE7-DE21-40C8-BE11-3ACF9BB5A9E7

Q33772319-1EEEE155-6DB9-4927-A7CA-3E9C37B56A48

Q33772319-2F3DF18C-AF34-4930-BBAA-69CDEC71F6EB

Q33772319-322E5389-4C83-4612-8217-D0D4EEB60209

Q33772319-4F4890C8-D321-4175-9CDC-E50A62562F0F

Q33772319-514EB8B5-0A66-427C-A0CE-92FE8A743FC4

Q33772319-5F2C279A-1979-4B2B-8B4C-D11573DA7712

P304

Q33772319-8BAF9F2D-6C90-491D-8100-55E15FF38F09

P31

Q33772319-585A1EAD-41D1-4CCF-B306-572AACE98D61

P356

Q33772319-AB1DCA9E-E3D2-46B2-A656-85E24E8E325C

P407

Q33772319-ADE502D6-B931-4D2C-B1B7-4846C4B130A4

P433

Q33772319-6B7CD1DD-8D0E-4F8E-BD14-40AEB5BD2B6F

P478

Q33772319-14024C71-8E01-425E-9AA3-110DF6A21E98

P50

Q33772319-01E10B20-930F-4958-BFDA-40982D3C2F5B

Q33772319-FD4E2BA1-4CF2-4F55-8B37-6ADE84555E6F

P577

Q33772319-83AB7549-2AE4-4EC3-9113-FCAEB5482815

P698

Q33772319-79C93E10-8828-4FBA-88EA-B722C602A94A

P932

Q33772319-9487F461-9A46-4E28-9B0C-79CEEA429C42

P356

P1433

P1476

Brain glucosamine boosts protective glucoprivic feeding

@en

P2093

Chen-Yu Yueh

http://www.w3.org/2001/XMLSchema#string

Jill Shaw

http://www.w3.org/2001/XMLSchema#string

Ligang Zhou

http://www.w3.org/2001/XMLSchema#string

Mayowa A Osundiji

http://www.w3.org/2001/XMLSchema#string

Robert Sherwin

http://www.w3.org/2001/XMLSchema#string

Stephen P Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus

Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing

Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia

Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms.

The need to feed: homeostatic and hedonic control of eating.

The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy.

Role of the glucosamine pathway in fat-induced insulin resistance.

P304

1499-1508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2009-0989

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20179264

http://www.w3.org/2001/XMLSchema#string

P932

2850228

http://www.w3.org/2001/XMLSchema#string